Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hypomyelination-congenital cataract is characterized by the onset of cataract either at birth or in the first two months of life, delayed psychomotor development by the end of the first year of life and moderate intellectual deficit.
Features include always present findings: Developmental cataract, CNS hypomyelination, Intellectual disability, and Overactive reflexes (hyperreflexia) and others; and very common findings: Decreased motor nerve conduction velocity, Polyneuropathy, Intention tremor, and Lower limb muscle weakness and others. 26 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 10 | Delayed brainstem auditory evoked response conduction time, Seizure, Polyneuropathy |
Muscles | 4 | Lower limb muscle weakness, Axial hypotonia, Cerebral white matter atrophy |
Arms and legs | 2 | Lower limb muscle weakness, Lower limb amyotrophy |
Eyes | 1 | Developmental cataract |
Bones and joints | 1 | Sideways curvature of the spine (scoliosis) |
Age of onset: at birth, adolescence.
Hypomyelination and congenital cataract (HCC) phenotype is quite consistent in the affected individuals described to date. Table 2. Hypomyelination and Congenital Cataract: Frequency of Select Features
Feature | Proportion of Persons w/Feature | Comment |
|---|---|---|
Bilateral congenital cataracts | 26/30 | — |
Developmental delay | 30/30 | — |
Intellectual disability | 30/30 |
HYCC1 encodes hyccin PI4KA lipid kinase complex subunit 1 (521 aa). Component of a complex required to localize phosphatidylinositol 4-kinase (PI4K) to the plasma membrane. The complex acts as a regulator of phosphatidylinositol 4-phosphate (PtdIns(4)P) synthesis. Highest expression in Cells Cultured fibroblasts (25.8 TPM) and Cells EBV-transformed lymphocytes (14.3 TPM).
Hypomyelinating leukodystrophy 5 is caused by mutations in the HYCC1 gene on chromosome 7.
HYCC1 is classified as a druggable target (Kinase category) with score 0.0.
Pathogenic variants leading to the complete absence of HYCC1 (formerly FAM126A) protein expression are associated with the full phenotype of bilateral cataract, central nervous system hypomyelination, and peripheral nerve hypomyelination. Pathogenic variants leading to a partial protein deficiency are associated with the milder form without peripheral nervous system involvement. An individual with deletion of exons 8 and 9 did not have congenital cataracts; cataracts developed at age nine years. A second individual had congenital unilateral cataract. However, of the four children in this family who survived beyond age two years, none was able to walk even with support after age six years .
Source: GeneReviews — "Hypomyelination and Congenital Cataract"
Hypomyelination and congenital cataract (HCC) should be suspected in individuals with the following clinical findings and characteristic abnormalities on brain MRI .
Clinical findings
Source: GeneReviews — "Hypomyelination and Congenital Cataract"
The association of congenital cataract and CNS hypomyelination is typical of hypomyelination and congenital cataract (HCC). However, the differential diagnosis with other hypomyelinating disorders should include the disorders summarized in . MRI usually shows areas with an even higher T2-weighted signal in HCC, whereas the white matter signal is homogeneously hyperintense in other hypomyelinating disorders. Table 3. Hypomyelinating Disorders of Interest in the Differential Diagnosis of Hypomyelination and Congenital Cataract
Gene(s) | DiffDx Disorder | MOI | Features of DiffDx Disorder |
|---|---|---|---|
PLP1 | Pelizaeus-Merzbacher disease (See PLP1 Disorders.) | XL | Spasticity/ataxia; nystagmus; hypomyelination |
GJC2 | Hypomyelinating leukodystrophy 2 (OMIM 608804) | AR | Spasticity/ataxia; nystagmus; hypomyelination, peripheral neuropathy, epilepsy |
Genetic testing for HYCC1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for hypomyelinating leukodystrophy 5 has been reported in the published literature.
No approved treatments are currently available for hypomyelinating leukodystrophy 5. The disease remains an area of unmet medical need.
To establish the extent of disease and needs in an individual diagnosed with hypomyelination and congenital cataract (HCC), the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 4.
Recommended Evaluations Following Initial Diagnosis in Individuals with Hypomyelination and Congenital Cataract
System/Concern | Evaluation | Comment
| Ophthalmologic exam |
| Developmental assessment | • Incl motor, adaptive, cognitive, speech-language eval for dysarthria
Eval for early intervention/ special education
| Neurologic eval for evidence of spasticity, ataxia, seizures | Consider EEG if seizures are a concern.
| Orthopedics/ physical medicine rehab/ PT OT eval | To incl assessment of:
Gross motor fine motor skills
Contractures, clubfoot, kyphoscoliosis
Mobility, activities of daily living, need for adaptive devices
Need for PT (to improve gross motor skills) /or OT (to improve fine motor skills)
Gastrointestinal/
| Gastroenterology/ nutrition/feeding team eval | • To incl eval of aspiration risk nutritional status
Consider eval for gastrostomy tube placement in those w/dysphagia /or aspiration risk.
| By genetics professionals1 | To inform affected persons their families re nature, MOI, implications of HCC to facilitate medical personal decision making
Family support
resources | Assess need for:
Source: GeneReviews — "Hypomyelination and Congenital Cataract"
None are known. Some individuals are prone to febrile seizures.
Source: GeneReviews — "Hypomyelination and Congenital Cataract"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Hypomyelination and Congenital Cataract"
View trials for hypomyelinating leukodystrophy 5
Table 6.
Recommended Surveillance for Individuals with Hypomyelination and Congenital Cataract
System/Concern | Evaluation | Frequency
| Eye exam if cataracts were not identified in the neonatal period |
| Monitor developmental progress educational needs. | At each visit
| Monitor those w/seizures as clinically indicated.
Assess for new manifestations incl seizures, changes in tone, movement disorders.
| Physical medicine, OT/PT assessment of mobility, self-help skills
| • Measurement of growth parameters
Eval of nutritional status safety of oral intake
Family/
| Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources) care coordination.
OT = occupational therapy; PT = physical therapy
Source: GeneReviews — "Hypomyelination and Congenital Cataract"
Phenotype severity distribution: 9 always present features, 7 very common features, 6 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hypomyelinating leukodystrophy 5.
125 publications have been identified in PubMed for hypomyelinating leukodystrophy 5. Kisho has analyzed 64 by research type. Research spans Review / Meta-Analysis (31%), Basic Science / Preclinical (27%), and Case Report / Case Series (23%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 20 | 31% |
Laboratory research | 17 | 27% |
Patient case studies | 15 | 23% |
Disease patterns and progression | 8 | 13% |
Clinical study results | 2 | 3% |
Testing and diagnosis research | 1 | 2% |
New treatment approaches | 1 | 2% |
Cassano F (2026). [PMID: 41615444](https://pubmed.ncbi.nlm.nih.gov/41615444/). *Graefes Arch Clin Exp Ophthalmol*. [Review / Meta-Analysis]
Runkle JR (2026). [PMID: 28722981](https://pubmed.ncbi.nlm.nih.gov/28722981/). *Unknown Journal*. [Basic Science / Preclinical]
Beale HC (2026). [PMID: 42090037](https://pubmed.ncbi.nlm.nih.gov/42090037/). *Hum Genet*. [Case Report / Case Series]
Tuteja S (2026). [PMID: 34662036](https://pubmed.ncbi.nlm.nih.gov/34662036/). *Unknown Journal*. [Basic Science / Preclinical]
Gjervan SC (2026). [PMID: 41932029](https://pubmed.ncbi.nlm.nih.gov/41932029/). *Stem Cell Res*. [Basic Science / Preclinical]
Moshirfar M (2026). [PMID: 39163461](https://pubmed.ncbi.nlm.nih.gov/39163461/). *Unknown Journal*. [Basic Science / Preclinical]
Firn K (2026). [PMID: 40465813](https://pubmed.ncbi.nlm.nih.gov/40465813/). *Unknown Journal*. [Basic Science / Preclinical]
Jat NS (2026). [PMID: 35593847](https://pubmed.ncbi.nlm.nih.gov/35593847/). *Unknown Journal*. [Epidemiology / Natural History]
Drobňaková S (2026). [PMID: 42195294](https://pubmed.ncbi.nlm.nih.gov/42195294/). *Life (Basel)*. [Epidemiology / Natural History]
Sase S (2026). [PMID: 41566774](https://pubmed.ncbi.nlm.nih.gov/41566774/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 6:42 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
—
Dysarthria | 26/26 | — |
Truncal hypotonia | 26/26 | — |
Brisk tendon reflexes bilateral extensor plantar responses | 30/30 | — |
Cerebellar signs | 11/25 | Truncal titubation, intention tremor |
Peripheral neuropathy | 22/24 | Muscle weakness, muscle wasting of the legs |
Seizures | 4/28 | Seizures may be prolonged w/fever. Ophthalmologic. Bilateral congenital cataracts identified at birth or within the first month of life are the first clinical sign. |
Source: GeneReviews — "Hypomyelination and Congenital Cataract"
AD |
Spasticity/ataxia; nystagmus; hypomyelination |
Hypomyelination, cerebellar atrophy, (in most cases) atrophy of the basal ganglia on MRI POLR1C POLR3A POLR3B POLR3K |
POLR3-related leukodystrophy | AR | Ataxia, hypodontia, hypogonadotropic hypogonadism, high myopia | Specific pattern of hypomyelination cerebellar atrophy on MRI AD = autosomal dominant; AR = autosomal recessive; DiffDx = differential diagnosis; HCC = hypomyelination and congenital cataract; MOI = mode of inheritance; XL = X-linked |
Source: GeneReviews — "Hypomyelination and Congenital Cataract"